Home › Funds › Orion Investment Co › IOVA

Orion Investment Co position in IOVA

Iovance Biotherapeutics Inc · Health Care

Orion Investment Co reported holding 2,083,377 shares of IOVA (Iovance Biotherapeutics Inc) in its Q3 2026 13F filing — a position valued at US$30.9M, representing 8.19% of its reported portfolio and ranking #2 among its reported holdings. Orion Investment Co has disclosed IOVA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)2.08M sh
Reported value held$30.88M
Portfolio Weight8.19%
First reportedQ2 2024
Last changeHold
Updated2026-11-11

Last updated: 2026-11-11 · Source: SEC EDGAR Form 13F-HR

How Orion Investment Co's IOVA position evolved

Orion Investment Co first disclosed a stake in IOVA in Q2 2024 at 794,700 shares (US$6.4M). The position peaked in Q3 2026 at 2,083,377 shares, worth US$30.9M. Across 10 filings, Orion Investment Co increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,083,377 shares valued at US$30.9M. Notable position changes include a 99% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 794.70K $6.37M New
Q3 2024 906.28K $8.51M Add
Q4 2024 1.06M $7.85M Add
Q1 2025 1.18M $3.92M Add
Q2 2025 2.34M $4.02M Add
Q3 2025 1.85M $4.02M Reduce
Q4 2025 1.86M $5.07M Hold
Q1 2026 2.07M $7.25M Add
Q2 2026 2.07M $8.62M Hold
Q3 2026 2.08M $30.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (Iovance Biotherapeutics Inc) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has Orion Investment Co held IOVA?

Orion Investment Co has disclosed IOVA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Orion Investment Co's current position in IOVA?

As of Q3 2026, Orion Investment Co holds 2.08M shares of IOVA (Iovance Biotherapeutics Inc), valued at $30.88M, representing 8.19% of its reported portfolio and ranking #2.

Has Orion Investment Co been buying or selling IOVA?

In the latest 13F filing (Q3 2026), Orion Investment Co held unchanged its position in IOVA. The position peaked in Q3 2026 at 2.08M shares.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.